Become a clinical research volunteer
Everyone who takes part in a clinical trial is a volunteer, regardless of whether they are healthy or are suffering from the condition the trial aims to treat.
Our volunteers enable us to assess a compound’s potential to become a new medicine. And they do more. Once a medicine has been approved for use we can, through further trials, continue to monitor its effect and obtain additional safety data.
Before each trial begins, we work with an independent ethics committee made up of lay people, medical professionals, scientists and investigators. This committee establishes an ‘informed consent’ process that gives potential volunteers a detailed picture of the study.
Those who take part in clinical trials must voluntarily confirm they are willing to participate, after being told about the study and its benefits and risks. The informed consent process involves more than just reading and signing a form. It is part of a wider process for communicating essential information about the trial, including:
- the trial’s purpose
- treatment procedures
- potential benefits and risks
- alternatives to participation (applies to patients with an existing condition – what other treatments are available if they do not want to take part in the trial)
- how confidentiality is maintained
- participants’ rights – including the right to end participation at any time
How to apply
If you would like to register as a potential trial volunteer in the UK, please visit www.volunteers.gsk.co.uk.
More about our research
Clinical trial phases
Each step of the clinical trial process is carefully monitored by government authorities and our own Global Safety Board (GSB)
Independent clinical studies
At GSK, we carry out a large number of studies on our products and we make this information available in a range of ways
What we are working on
GSK has a deep portfolio of innovation, focussed across six core areas of scientific research and development
How we discover our new products
Find out how we discover and develop new products, and how patient safety is always our number one priority